<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00608998</url>
  </required_header>
  <id_info>
    <org_study_id>UF 7853</org_study_id>
    <nct_id>NCT00608998</nct_id>
  </id_info>
  <brief_title>Identification of Cardiovascular Risk Factors Linked to Renal Failure Progression</brief_title>
  <acronym>Pre-HD</acronym>
  <official_title>Vascular Risk Factors and Coronary Calcifications in Chronic Renal Failure Patients: Identification of Specific Factors Linked to Renal Failure Progression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to appreciate the influence of renal failure progression on
      vasculopathy (coronary calcifications and left ventricular hypertrophy) and cardiovascular
      risk factors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to appreciate the relationship between:

        -  extension of coronary calcifications and chronic renal failure progression

        -  extension of coronary calcifications and levels of osteoprotegerin (bone disease marker)

        -  cardiovascular risk factors and coronary calcifications

        -  cardiovascular risk factors and existence of cardiovascular diseases
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2007</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>description of osteoprotegerin levels according to chronic renal failure progression</measure>
    <time_frame>inclusion</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>calcium score description according to chronic renal failure progression</measure>
    <time_frame>inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>osteoprotegerin description according to calcium score</measure>
    <time_frame>inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>relationship between cardiovascular risk factors and calcium score</measure>
    <time_frame>inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>relationship between cardiovascular risk factors and cardiovascular disease</measure>
    <time_frame>inclusion</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Chronic Renal Failure</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood white cells serum plasma urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient who has signed the written consent form

          -  Patient aged &gt; 18 and &lt; 90 years

          -  Chronic renal failure defined by glomerular filtration rate (GFR)

               -  group 1: GFR &gt;90 mL/min with urinary biological abnormalities and GFR comprised
                  between 90 and 60 mL/min

               -  group 2: GFR comprised between 60 and 30 mL/min

               -  group 3: GFR &lt;30 mL/min but without dialysis therapy

        Exclusion Criteria:

          -  Chronic renal failure patient requiring dialysis therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernard CANAUD, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Lapeyronie Montpellier France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Paul CRISTOL, Pr</last_name>
    <role>Study Chair</role>
    <affiliation>CHU Lapeyronie Montpellier France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hélène VERNHET, Pr</last_name>
    <role>Study Chair</role>
    <affiliation>CHU Arnaud de Villeneuve Montpellier France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kada KLOUCHE, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>CHU Lapeyronie Montpellier France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hélène LERAY-MORAGUES, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>CHU Lapeyronie Montpellier France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bernard CANAUD, Pr</last_name>
    <phone>00 33 4 67 33 84 95</phone>
    <email>b-canaud@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernard CANAUD, Pr</last_name>
      <phone>00 33 4 67 33 84 95</phone>
      <email>b-canaud@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Bernard CANAUD, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Paul CRISTOL, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hélène VERNHET, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kada KLOUCHE, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hélène LERAY-MORAGUES, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2008</study_first_submitted>
  <study_first_submitted_qc>February 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2008</study_first_posted>
  <last_update_submitted>March 28, 2011</last_update_submitted>
  <last_update_submitted_qc>March 28, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2011</last_update_posted>
  <responsible_party>
    <name_title>Prof Bernard CANAUD</name_title>
    <organization>Centre Hospitalier Universitaire Montpellier France</organization>
  </responsible_party>
  <keyword>Chronic renal failure</keyword>
  <keyword>Vasculopathy</keyword>
  <keyword>Cardiovascular risk</keyword>
  <keyword>Chronic renal failure patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

